Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Theobromine is a dimethylxanthine alkaloid derived from the cocoa tree, with a bitter taste and an odorless white crystalline powder appearance. It is a weak base and a derivative of caffeine, exhibiting mild stimulant and diuretic properties. Theobromine is soluble in water and can be purified by sublimation, forming colorless rhombic microcrystals. It is also found in cocoa beans, cocoa powder, cola nut, and tea.

83-67-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 83-67-0 Structure
  • Basic information

    1. Product Name: Theobromine
    2. Synonyms: 3,7-dihydro-3,7-dimethyl-1h-purine-6-dione;3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione;3,7-dimethyl-xanthin;6-dione,3,7-dihydro-3,7-dimethyl-1H-Purine-2;Diurobromine;Santheose;SC 15090;sc15090
    3. CAS NO:83-67-0
    4. Molecular Formula: C7H8N4O2
    5. Molecular Weight: 180.16
    6. EINECS: 201-494-2
    7. Product Categories: Alkaloid;Building Blocks;Chemical Synthesis;Heterocyclic Building Blocks;Nutrition Research;Phytochemicals by Chemical Classification;Purines;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals;THESODATE;Isolabel;Inhibitors;Heterocyclic Compounds;Alkaloids;Alkaloids (Others);Biochemistry;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals
    8. Mol File: 83-67-0.mol
  • Chemical Properties

    1. Melting Point: 345-350 °C
    2. Boiling Point: 312.97°C (rough estimate)
    3. Flash Point: 290-295°C
    4. Appearance: white/solid
    5. Density: 1.50
    6. Refractive Index: 1.6700 (estimate)
    7. Storage Temp.: Refrigerator
    8. Solubility: H2O: slightly soluble
    9. PKA: 7.89(at 18℃)
    10. Water Solubility: slightly soluble,
    11. Merck: 14,9282
    12. BRN: 16464
    13. CAS DataBase Reference: Theobromine(CAS DataBase Reference)
    14. NIST Chemistry Reference: Theobromine(83-67-0)
    15. EPA Substance Registry System: Theobromine(83-67-0)
  • Safety Data

    1. Hazard Codes: Xn,Xi,T,F
    2. Statements: 22-36/37/38-39/23/24/25-23/24/25-11
    3. Safety Statements: 22-24/25-36-26-45-36/37-16-7
    4. RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
    5. WGK Germany: 1
    6. RTECS: XH2275000
    7. F: 10-23
    8. TSCA: Yes
    9. HazardClass: N/A
    10. PackingGroup: N/A
    11. Hazardous Substances Data: 83-67-0(Hazardous Substances Data)

83-67-0 Usage

Uses

Used in Pharmaceutical Industry:
Theobromine is used as a diuretic, bronchodilator, and cardiotonic agent due to its mild stimulant and diuretic actions.
Used in Food Industry:
Theobromine is used as a flavoring agent and a mild stimulant in various food products, particularly in chocolate and cocoa-based items.
Used in Research:
Theobromine is used as an adenosine A1 receptor antagonist in scientific research, with potential applications in studying the effects of this receptor on various biological processes.
Used in Veterinary Medicine:
Theobromine is toxic to dogs, with an LD50 value of 250 to 500 mg/kg, and is used as a reference substance for studying toxicity and developing antidotes in veterinary medicine.

Air & Water Reactions

Insoluble in water.

Reactivity Profile

Theobromine may be sensitive to prolonged exposure to light. Theobromine has weakly acidic properties, combining with bases to forms salts. Theobromine also has even weaker basic properties, combining with acids to form salts which are decomposed in aqueous solution. .

Fire Hazard

Flash point data for Theobromine are not available; however, Theobromine is probably combustible.

Flammability and Explosibility

Nonflammable

Safety Profile

Poison by ingestion. Moderately toxic by subcutaneous route. An experimental teratogen. Human systemic effects by ingestion: central nervous system and gastrointestinal changes. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. Used as a diuretic, smooth muscle relaxant, cardiac stimulant, and vasoddator.

Purification Methods

It crystallises from H2O. Its solubility in H2O is 0.06% at 15o and 1.25% at 100o, and it is poorly soluble in organic solvents. It forms salts with heavy metals and is a diuretic, vasodilator and a cardiac stimulant. [Lister Purines Part II, Fused Pyrimidines Brown Ed, Wiley-Interscience pp254-225 1971, ISBN 0-471-38205-1, Beilstein 26 H 457, 26 I 135, 26 II 264, 26 III/IV 2336.]

References

Biltz, Max., Annalen, 423,320 (1921) Dubosc., Chem. Zentr., IV, 956 (1932) Gepner, Kreps., Chem. Abstr., 41,96 (1947) Bohinc, Korber-Smid, J agodic., Farm. Vestn., (Ljubljana), 23, 143 (1972)

Check Digit Verification of cas no

The CAS Registry Mumber 83-67-0 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 8 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 83-67:
(4*8)+(3*3)+(2*6)+(1*7)=60
60 % 10 = 0
So 83-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3,7,13H,1-2H3,(H,9,12)

83-67-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T0178)  Theobromine  >98.0%(HPLC)(T)

  • 83-67-0

  • 25g

  • 273.00CNY

  • Detail
  • TCI America

  • (T0178)  Theobromine  >98.0%(HPLC)(T)

  • 83-67-0

  • 100g

  • 707.00CNY

  • Detail
  • TCI America

  • (T0178)  Theobromine  >98.0%(HPLC)(T)

  • 83-67-0

  • 500g

  • 2,220.00CNY

  • Detail
  • Alfa Aesar

  • (A11861)  Theobromine, 99%   

  • 83-67-0

  • 50g

  • 547.0CNY

  • Detail
  • Alfa Aesar

  • (A11861)  Theobromine, 99%   

  • 83-67-0

  • 100g

  • 596.0CNY

  • Detail
  • Alfa Aesar

  • (A11861)  Theobromine, 99%   

  • 83-67-0

  • 250g

  • 1352.0CNY

  • Detail

83-67-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name theobromine

1.2 Other means of identification

Product number -
Other names Diurobromine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83-67-0 SDS

83-67-0Synthetic route

1-amino-3,7-dimethylxanthine
81281-47-2

1-amino-3,7-dimethylxanthine

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium nitrite In acetic acid96%
3-methylxanthine
1076-22-8

3-methylxanthine

dimethyl sulfate
77-78-1

dimethyl sulfate

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
Stage #1: 3-methylxanthine; dimethyl sulfate With sodium hydrogencarbonate In water; acetone at 55 - 60℃; for 4h;
Stage #2: With hydrogenchloride In water at 80℃; pH=5 - 6; Product distribution / selectivity;
87%
3-methylxanthine disodium salt

3-methylxanthine disodium salt

dimethyl sulfate
77-78-1

dimethyl sulfate

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
Stage #1: 3-methylxanthine disodium salt; dimethyl sulfate With sodium carbonate In acetone at 55 - 57℃; for 4h;
Stage #2: With hydrogenchloride In water at 30℃; pH=6; Product distribution / selectivity;
84.9%
3,7,9-trimethylxanthinium hydrogensulfate

3,7,9-trimethylxanthinium hydrogensulfate

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
at 260℃; for 1h;66%
3-methylxanthine
1076-22-8

3-methylxanthine

methyl iodide
74-88-4

methyl iodide

A

theobromine /
83-67-0

theobromine /

B

1,7,9-trimethylxanthinium iodide
86180-33-8

1,7,9-trimethylxanthinium iodide

Conditions
ConditionsYield
at 110℃; for 1.5h; closed Kjeldahl flask;A 61%
B 28%
5-amino-3-methyl-3H-imidazole-4-carboxylic acid methylamide; hydrochloride
94453-49-3

5-amino-3-methyl-3H-imidazole-4-carboxylic acid methylamide; hydrochloride

urea
57-13-6

urea

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
In melt 1) 140 deg C, 30 min 2) 170-175 deg C, 2h;55%
3,7,9-trimethylxanthinium perchlorate

3,7,9-trimethylxanthinium perchlorate

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
In pyridine at 115℃; for 3h;53%
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

A

theophylline
58-55-9

theophylline

B

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium thiophenolate at 250℃; for 1.5h;A 37%
B 21%
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

A

theophylline
58-55-9

theophylline

B

theobromine /
83-67-0

theobromine /

C

paraxanthine
611-59-6

paraxanthine

Conditions
ConditionsYield
With hepatic cytochrome P450 Enzymatic reaction;A 7%
B 12%
C n/a
theophylline
58-55-9

theophylline

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium thiophenolate at 280℃; for 1.5h;10%
3-methyl-4-amino-5-formylamino-2,6-dioxypyrimidine
14785-95-6

3-methyl-4-amino-5-formylamino-2,6-dioxypyrimidine

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium hydroxide anschliessendes Behandeln mit Dimethylsulfat;
ethanol
64-17-5

ethanol

3,7-dimethyl-3,7-dihydro-purine-2,6-dione, theobromine; salicylate
519-41-5

3,7-dimethyl-3,7-dihydro-purine-2,6-dione, theobromine; salicylate

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
Ausscheidung;
3-methyl-5-(N-methyl-ureido)-3H-imidazole-4-carboxylic acid methylamide

3-methyl-5-(N-methyl-ureido)-3H-imidazole-4-carboxylic acid methylamide

acetic acid
64-19-7

acetic acid

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
Erhitzen ueber den Schmelzpunkt;
3,7-dimethyl-8-trichloromethyl-3,7-dihydro-purine-2,6-dione
117882-90-3

3,7-dimethyl-8-trichloromethyl-3,7-dihydro-purine-2,6-dione

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With hydrogenchloride
1-benzoyl-3,7-dimethyl-3,7-dihydro-purine-2,6-dione
80038-09-1

1-benzoyl-3,7-dimethyl-3,7-dihydro-purine-2,6-dione

furan-2,3,5(4H)-trione pyridine (1:1)

furan-2,3,5(4H)-trione pyridine (1:1)

glycine
56-40-6

glycine

A

Hippuric Acid
495-69-2

Hippuric Acid

B

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
at 20℃;
dimethyl sulfate
77-78-1

dimethyl sulfate

xanthin
69-89-6

xanthin

theobromine /
83-67-0

theobromine /

dimethyl sulfate
77-78-1

dimethyl sulfate

xanthin
69-89-6

xanthin

A

theobromine /
83-67-0

theobromine /

B

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

Conditions
ConditionsYield
bei der Methylierung unter verschiedenen Bedingungen;
xanthin
69-89-6

xanthin

methyl iodide
74-88-4

methyl iodide

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
at 100℃; Das Bleisalz liefert beim Erhitzen im Rohr;
chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

3-Methyl-5-methylamino-3H-imidazole-4-carboxylic acid amide; compound with perchloric acid
115377-65-6

3-Methyl-5-methylamino-3H-imidazole-4-carboxylic acid amide; compound with perchloric acid

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium hydroxide; triethylamine 1.) MeCN, r. t., 1.5 h, 2.) r. t., 10 min; Yield given. Multistep reaction;
7,9-dimethylxanthinium iodide
86180-29-2

7,9-dimethylxanthinium iodide

A

theobromine /
83-67-0

theobromine /

B

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 230℃; for 0.75h; Title compound not separated from byproducts;
7,9-dimethylxanthinium hydrogensulfate

7,9-dimethylxanthinium hydrogensulfate

A

theobromine /
83-67-0

theobromine /

B

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 250℃; for 0.25h; Title compound not separated from byproducts;
7,9-dimethylxanthinium betaine
5752-21-6

7,9-dimethylxanthinium betaine

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With iodine at 250℃; for 1h;
3,7,9-trimethylxanthinium chloride
86180-34-9

3,7,9-trimethylxanthinium chloride

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
at 260℃; for 0.75h; Yield given;
3-methyl-4-methylamino-5-methylformylaminouracil
90198-42-8

3-methyl-4-methylamino-5-methylformylaminouracil

A

theobromine /
83-67-0

theobromine /

B

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

Conditions
ConditionsYield
fusion;
1,7,9-trimethylxanthinium iodide
86180-33-8

1,7,9-trimethylxanthinium iodide

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
at 230℃; for 0.25h; Yield given;
(5-Carbamoyl-1-methyl-1H-imidazol-4-yl)-methyl-carbamic acid ethyl ester

(5-Carbamoyl-1-methyl-1H-imidazol-4-yl)-methyl-carbamic acid ethyl ester

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With sodium hydroxide for 0.166667h; Heating; Yield given;
3,7-dimethyl-6-(5-oxohexyloxy)-3,7-dihydro-2H-purin-2-one
93079-86-8

3,7-dimethyl-6-(5-oxohexyloxy)-3,7-dihydro-2H-purin-2-one

A

theobromine /
83-67-0

theobromine /

B

6-hydroxy-2-hexanone
21856-89-3

6-hydroxy-2-hexanone

Conditions
ConditionsYield
With hydrogenchloride
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

A

formaldehyd
50-00-0

formaldehyd

B

theobromine /
83-67-0

theobromine /

Conditions
ConditionsYield
With Tris-HCl buffer; 1,4-dihydronicotinamide adenine dinucleotide; Pseudomonas putida No. 352 at 25℃; Product distribution; various substrates, enzyme activity;
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

A

theophylline
58-55-9

theophylline

B

theobromine /
83-67-0

theobromine /

C

1,3,7-trimethyl-7,9-dihydro-3H-purine-2,6,8-trione
5415-44-1

1,3,7-trimethyl-7,9-dihydro-3H-purine-2,6,8-trione

Conditions
ConditionsYield
With dihydrogen peroxide In water Product distribution; Mechanism; Irradiation; other reagent;
theobromine /
83-67-0

theobromine /

11-chloroundec-1-ene
872-17-3

11-chloroundec-1-ene

1-(10-undecenyl)-3,7-dimethylxanthine
156918-64-8

1-(10-undecenyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
With potassium carbonate In water; dimethyl sulfoxide100%
theobromine /
83-67-0

theobromine /

δ-chlorovaleronitrile
6280-87-1

δ-chlorovaleronitrile

5-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanenitrile

5-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanenitrile

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 130℃; for 3h;100%
theobromine /
83-67-0

theobromine /

9-bromo-1-nonene
89359-54-6

9-bromo-1-nonene

1-(8-nonenyl)-3,7-dimethylxanthine
156918-55-7

1-(8-nonenyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
In dimethyl sulfoxide99%
In dimethyl sulfoxide99%
In dimethyl sulfoxide99%
In dichloromethane; dimethyl sulfoxide99%
theobromine /
83-67-0

theobromine /

6-Bromo-1-hexene
2695-47-8

6-Bromo-1-hexene

1-(hex-5-enyl)-3,7-dimethylxanthine
58999-18-1

1-(hex-5-enyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
In water; dimethyl sulfoxide98%
In water; dimethyl sulfoxide95.5%
theobromine /
83-67-0

theobromine /

(E)-1-bromohex-1-ene
13154-13-7

(E)-1-bromohex-1-ene

1-(hex-5-enyl)-3,7-dimethylxanthine
58999-18-1

1-(hex-5-enyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
In water; dimethyl sulfoxide98%
In water; dimethyl sulfoxide98%
In water; dimethyl sulfoxide
In water; dimethyl sulfoxide
theobromine /
83-67-0

theobromine /

(E)-1-bromohex-1-ene
13154-13-7

(E)-1-bromohex-1-ene

A

1-(hex-5-enyl)-3,7-dimethylxanthine
58999-18-1

1-(hex-5-enyl)-3,7-dimethylxanthine

B

1-(5,6-oxidohexyl)-3,7-dimethylxanthine
154719-57-0

1-(5,6-oxidohexyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
In water; dimethyl sulfoxideA 98%
B n/a
In water; dimethyl sulfoxideA 98%
B n/a
theobromine /
83-67-0

theobromine /

8-iodotheobromine
86444-90-8

8-iodotheobromine

Conditions
ConditionsYield
With iodine In acetonitrile for 1.5h; Heating;97%
theobromine /
83-67-0

theobromine /

8-Bromo-1-octene
2695-48-9

8-Bromo-1-octene

1-(7-octenyl)-3,7-dimethylxanthine

1-(7-octenyl)-3,7-dimethylxanthine

Conditions
ConditionsYield
In dimethyl sulfoxide97%
In dimethyl sulfoxide97%
theobromine /
83-67-0

theobromine /

1-bromo-octane
111-83-1

1-bromo-octane

3,7-dimethyl-1-octyl-3,7-dihydro-1H-purine-2,6-dione
103976-48-3

3,7-dimethyl-1-octyl-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 120℃; Inert atmosphere;96%
With potassium carbonate In N,N-dimethyl-formamide at 120℃; Inert atmosphere; Schlenk technique;88%
With potassium hydroxide; Aliquat 336 1.) 80 deg C, 2 h, 2.) 1 h; Yield given. Multistep reaction;
theobromine /
83-67-0

theobromine /

1,3-Dichloropropane
142-28-9

1,3-Dichloropropane

1-(3-chloropropyl)-3,7-dimethyl-2,3,6,7-tetrahydro-1H-2,6-purinedione
74409-52-2

1-(3-chloropropyl)-3,7-dimethyl-2,3,6,7-tetrahydro-1H-2,6-purinedione

Conditions
ConditionsYield
With sodium hydroxide; N-benzyl-N,N,N-triethylammonium chloride for 2h; Heating;96%
theobromine /
83-67-0

theobromine /

benzyl bromide
100-39-0

benzyl bromide

3,7-dimethyl-9-benzylxanthinium bromide
1243688-83-6

3,7-dimethyl-9-benzylxanthinium bromide

Conditions
ConditionsYield
With potassium iodide for 24h; Reflux; Inert atmosphere;96%
theobromine /
83-67-0

theobromine /

2,6-dichloro-7-methylpurine
2273-93-0

2,6-dichloro-7-methylpurine

Conditions
ConditionsYield
With trichlorophosphate; phosphorus trichloride Substitution;95%
With trichlorophosphate at 140℃;
With N,N-diethylaniline; trichlorophosphate at 130℃; for 18h; Inert atmosphere;
With trichlorophosphate at 140℃;
theobromine /
83-67-0

theobromine /

benzyl bromide
100-39-0

benzyl bromide

1-benzyl-3,7-dimethylxanthine
55247-90-0

1-benzyl-3,7-dimethylxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Inert atmosphere; Schlenk technique;95%
Stage #1: theobromine / With potassium carbonate In N,N-dimethyl-formamide for 0.5h;
Stage #2: benzyl bromide In N,N-dimethyl-formamide
89%
With caesium carbonate In toluene; acetonitrile for 18h;80%
theobromine /
83-67-0

theobromine /

allyl bromide
106-95-6

allyl bromide

N-allyltheobromine
2530-99-6

N-allyltheobromine

Conditions
ConditionsYield
Stage #1: theobromine /; allyl bromide With sodium t-butanolate In N,N-dimethyl-formamide at 150℃; for 12h;
Stage #2: In N,N-dimethyl-formamide at 100℃; for 12h;
95%
With potassium carbonate In N,N-dimethyl-formamide80%
With hydrogenchloride In dimethyl sulfoxide42%
theobromine /
83-67-0

theobromine /

1-chloro-5-hexyne
10297-06-0

1-chloro-5-hexyne

1-(hex-5-yn-1-yl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione

1-(hex-5-yn-1-yl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 100℃; for 2h;95%
theobromine /
83-67-0

theobromine /

12-phosphotungstic acid*29H2O

12-phosphotungstic acid*29H2O

ethanol
64-17-5

ethanol

O40PW12(3-)*3C7H9N4O2(1+)*1.5C2H6O

O40PW12(3-)*3C7H9N4O2(1+)*1.5C2H6O

Conditions
ConditionsYield
Stage #1: theobromine /; 12-phosphotungstic acid*29H2O In water at 70 - 80℃;
Stage #2: ethanol
95%
methyl bromide
74-83-9

methyl bromide

theobromine /
83-67-0

theobromine /

A

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

B

3-benzyladenine
7280-81-1

3-benzyladenine

Conditions
ConditionsYield
With solution aqueuse d'hydroxide de sodium; tetrabutylammomium bromide In dichloromethane 1)20 deg C, 12h 2)40 deg C, 3h;A 94%
B n/a
Iodoethanol
624-76-0

Iodoethanol

theobromine /
83-67-0

theobromine /

1-(2-hydroxyethyl)-3,7-dimethyl-3,7-dihydropurine-2,6-dione
1507-14-8

1-(2-hydroxyethyl)-3,7-dimethyl-3,7-dihydropurine-2,6-dione

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide for 4h;94%
Stage #1: theobromine / With potassium carbonate In N,N-dimethyl-formamide Reflux;
Stage #2: Iodoethanol for 18h; Reflux;
68%
theobromine /
83-67-0

theobromine /

1-propylhalide

1-propylhalide

3,7-Dimethyl-1-propylxanthine
63906-63-8

3,7-Dimethyl-1-propylxanthine

Conditions
ConditionsYield
Stage #1: theobromine / With sodium hydride In dimethyl sulfoxide at 60℃; for 0.333333h; Inert atmosphere;
Stage #2: 1-propylhalide In dimethyl sulfoxide at 60℃; Inert atmosphere;
94%
theobromine /
83-67-0

theobromine /

1-chloro-4-pentyne
14267-92-6

1-chloro-4-pentyne

3,7-dimethyl-1-(pent-4-yn-1-yl)-1H-purine-2,6(3H,7H)-dione

3,7-dimethyl-1-(pent-4-yn-1-yl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 100℃; for 2h;94%
theobromine /
83-67-0

theobromine /

5,8-dioxa-spiro[3,4]octane-2-ylmethyl methanesulfonate

5,8-dioxa-spiro[3,4]octane-2-ylmethyl methanesulfonate

1-(5,8-dioxa-spiro[3,4]octane-2-ylmethyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)dione

1-(5,8-dioxa-spiro[3,4]octane-2-ylmethyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 130℃; for 3.5h;93%
theobromine /
83-67-0

theobromine /

dimethyl sulfate
77-78-1

dimethyl sulfate

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

Conditions
ConditionsYield
potassium fluoride on basic alumina In acetonitrile for 24h; Ambient temperature;92%
With sodium hydroxide
theobromine /
83-67-0

theobromine /

2,6-dithiotheobromine
18904-08-0

2,6-dithiotheobromine

Conditions
ConditionsYield
With Lawessons reagent; aluminum oxide for 0.116667h; microwave irradiation;92%
With kerosine
theobromine /
83-67-0

theobromine /

bromopentene
1119-51-3

bromopentene

1-(Pent-4-enyl)-3,7-dimethyl-xanthine

1-(Pent-4-enyl)-3,7-dimethyl-xanthine

Conditions
ConditionsYield
In water; dimethyl sulfoxide; Petroleum ether92%
theobromine /
83-67-0

theobromine /

(5-oxohexyl) mesylate

(5-oxohexyl) mesylate

pentoxyphylline
6493-05-6

pentoxyphylline

Conditions
ConditionsYield
With potassium carbonate In ethanol; water at 50℃; for 16h;91.1%
theobromine /
83-67-0

theobromine /

1-bromo-6-hexanol
4286-55-9

1-bromo-6-hexanol

1-(6-hydroxy-hexyl)-3,7-dimethyl-3,7-dihydro-purine-2,6-dione
56395-71-2

1-(6-hydroxy-hexyl)-3,7-dimethyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
In water; dimethyl sulfoxide91%
In water; dimethyl sulfoxide91%
ethanol-dichloromethane

ethanol-dichloromethane

theobromine /
83-67-0

theobromine /

1-bromo-6-hexanol
4286-55-9

1-bromo-6-hexanol

1-(6-hydroxy-hexyl)-3,7-dimethyl-3,7-dihydro-purine-2,6-dione
56395-71-2

1-(6-hydroxy-hexyl)-3,7-dimethyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
In water; dimethyl sulfoxide91%
In water; dimethyl sulfoxide91%
theobromine /
83-67-0

theobromine /

zirconyl chloride octahydrate

zirconyl chloride octahydrate

ZrO(C5H2N4(O)2(CH3)2)2(C5HN4(O)2(CH3)2)Cl(H2O)

ZrO(C5H2N4(O)2(CH3)2)2(C5HN4(O)2(CH3)2)Cl(H2O)

Conditions
ConditionsYield
In ethanol Zr-compound refluxed in ethanol/triethyl orthoformate for 2 h; N-compound added and refluxed for 36 h; cooled to room temp.; filtered; washed with acetone; elem. anal.;91%
theobromine /
83-67-0

theobromine /

Methyl 4-(bromomethyl)benzoate
2417-72-3

Methyl 4-(bromomethyl)benzoate

4-((3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzoic acid methyl ester

4-((3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzoic acid methyl ester

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 25 - 110℃; for 3h; Inert atmosphere;91%

83-67-0Relevant articles and documents

SERS multiplexing of methylxanthine drug isomersviahost-guest size matching and machine learning

Chio, Weng-I Katherine,Dinish, U. S.,Jones, Tabitha,Lee, Tung-Chun,Liu, Jia,Olivo, Malini,Parkin, Ivan P.,Perumal, Jayakumar

supporting information, p. 12624 - 12632 (2021/10/06)

Multiplexed detection and quantification of structurally similar drug molecules, methylxanthine MeX, incl. theobromine TBR, theophylline TPH and caffeine CAF, have been demonstratedviasolution-based surface-enhanced Raman spectroscopy (SERS), achieving highly reproducible SERS signals with detection limits down to ~50 nM for TBR and TPH, and ~1 μM for CAF. Our SERS substrates are formed by aqueous self-assembly of gold nanoparticles (Au NPs) and supramolecular host molecules, cucurbit[n]urils (CBn,n= 7, 8). We demonstrate that the binding constants can be significantly increased using a host-guest size matching approach, which enables effective enrichment of analyte molecules in close proximity to the plasmonic hotspots. The dynamic range and the robustness of the sensing scheme can be extended using machine learning algorithms, which shows promise for potential applications in therapeutic drug monitoring, food processing, forensics and veterinary science.

Method for preparing a theobromine (by machine translation)

-

, (2017/03/08)

The present invention provides a kind of theobromine the preparation method is as follows: the caffeine by adding the alkali solution, coffee is obtained by reacting the carboxylic acid; the stated caffeinum carboxylic acid reaction with the sodium, is theobromine carboxylic acid; the said therbromine reaction of carboxylic acid and strong alkali, closed-loop generation theobromine sodium salt; the the said therbromine sodium salt with weak acid neutralization, be theobromine. This invention can be obtained through the four-step theobromine, simple process, shorten the production cycle is short. Experimental results show that, the method of the present invention to achieve preparation theobromine the yield of 48% - 50%, the yield is high. (by machine translation)

Biochemical Studies of Mycobacterial Fatty Acid Methyltransferase: A Catalyst for the Enzymatic Production of Biodiesel

Petronikolou, Nektaria,Nair, Satish K.

, p. 1480 - 1490 (2015/12/01)

Summary Transesterification of fatty acids yields the essential component of biodiesel, but current processes are cost-prohibitive and generate waste. Recent efforts make use of biocatalysts that are effective in diverting products from primary metabolism to yield fatty acid methyl esters in bacteria. These biotransformations require the fatty acid O-methyltransferase (FAMT) from Mycobacterium marinum (MmFAMT). Although this activity was first reported in the literature in 1970, the FAMTs have yet to be biochemically characterized. Here, we describe several crystal structures of MmFAMT, which highlight an unexpected structural conservation with methyltransferases that are involved in plant natural product metabolism. The determinants for ligand recognition are analyzed by kinetic analysis of structure-based active-site variants. These studies reveal how an architectural fold employed in plant natural product biosynthesis is used in bacterial fatty acid O-methylation. Mycobacterial fatty acid methyltransferases are employed as biocatalysts for the production of biodiesel. Petronikolou and Nair describe structural and biochemical characterization of a mycobacterial fatty acid methyltransferase, reveal an unexpected homology to enzymes involved in plant primary metabolism, and provide insights into substrate preference.

Molecular and biochemical characterization of caffeine synthase and purine alkaloid concentration in guarana fruit

Schimpl, Flávia Camila,Kiyota, Eduardo,Mayer, Juliana Lischka Sampaio,Gon?alves, José Francisco De Carvalho,Da Silva, José Ferreira,Mazzafera, Paulo

, p. 25 - 36 (2014/08/18)

Guarana seeds have the highest caffeine concentration among plants accumulating purine alkaloids, but in contrast with coffee and tea, practically nothing is known about caffeine metabolism in this Amazonian plant. In this study, the levels of purine alkaloids in tissues of five guarana cultivars were determined. Theobromine was the main alkaloid that accumulated in leaves, stems, inflorescences and pericarps of fruit, while caffeine accumulated in the seeds and reached levels from 3.3% to 5.8%. In all tissues analysed, the alkaloid concentration, whether theobromine or caffeine, was higher in young/immature tissues, then decreasing with plant development/maturation. Caffeine synthase activity was highest in seeds of immature fruit. A nucleotide sequence (PcCS) was assembled with sequences retrieved from the EST database REALGENE using sequences of caffeine synthase from coffee and tea, whose expression was also highest in seeds from immature fruit. The PcCS has 1083 bp and the protein sequence has greater similarity and identity with the caffeine synthase from cocoa (BTS1) and tea (TCS1). A recombinant PcCS allowed functional characterization of the enzyme as a bifunctional CS, able to catalyse the methylation of 7-methylxanthine to theobromine (3,7-dimethylxanthine), and theobromine to caffeine (1,3,7-trimethylxanthine), respectively. Among several substrates tested, PcCS showed higher affinity for theobromine, differing from all other caffeine synthases described so far, which have higher affinity for paraxanthine. When compared to previous knowledge on the protein structure of coffee caffeine synthase, the unique substrate affinity of PcCS is probably explained by the amino acid residues found in the active site of the predicted protein.

Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: Phenolics and caffeine metabolites

Rathod,Patel,Das,Tipparaju,Shinde,Anderson, Robert F.

, p. 480 - 487 (2013/07/19)

Epidemiological studies have associated coffee consumption with an inverse risk of developing Parkinson's disease, hepatocellular carcinoma and cirrhosis. The molecular mechanisms by which low concentrations of the constituents of coffee measured in human plasma can reduce the incidence of such diseases are not clear. Using an in vitro plasmid DNA system and radiolytically generated reactive oxygen species under constant radical scavenging conditions, we have shown that coffee chlorogenic acid, its derivatives and certain metabolites of caffeine reduce some of the free radical damage sustained to the DNA. A reduction in the amount of prompt DNA single-strand breaks (SSBs) was observed for all compounds whose radical one-electron reduction potential is a limited antioxidant role for such compounds in their interaction with DNA radicals.

Hair Treatment Means With Cloudberry Extract

-

, (2011/02/26)

Extract of cloudberries (Rubus chamaemorus) for use in agents for treating keratin fibers, particularly human hair, for improving the moisture in the fiber, repairing and restructuring the fibers and for protecting the fibers from oxidants and UV radiation, and for improving the color retention and color intensity when the fibers are colored hairs is disclosed.

THEOBROMINE PRODUCTION PROCESS

-

Page/Page column 12; 13, (2009/08/16)

A process for preparing theobromine by methylating 3-methyl xanthine disodium salt comprises reacting 3-methyl xanthine disodium salt with dimethyl sulfate by using acetone as solvent in the presence of sodium carbonate and acidifying. The present application also provides a process for refining theobromine which comprises dissolving coarse theobromine in liquid alkaline solution, decolorizing, filtering, adding reducing agent in filtrate, and acidifying at 60-80 °C until pH is 5-6, filtering, and drying to obtain theobromine.

HAIR TREATMENT PRODUCTS COMPRISING POLYMERS

-

, (2009/12/24)

The invention relates to hair treatment products, comprising at least one copolymer made of 0.1 to 50% (in relation to the total number of monomers in the copolymer) monomers of the formula (I), wherein the unknowns are defined as in claim 1, and A2) are monomers from the group of acrylic acid, methacrylic acid and the like, and—optionally non-ionic monomers from the group of acrylamide, vinyl alcohol, and the like, wherein the monomers A2 and A3 together represent 50 to 99.9% (in relation to the total number of monomers in the copolymer) of the copolymer, at least one silicon and at least one selected care product, wherein the products result in advantageous effects for skin and hair.

Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: The pathway and concentration dependence

Kot, Marta,Daniel, Wladyslawa A.

, p. 1538 - 1549 (2008/09/16)

The aim of the present study was to estimate the relative contribution of rat P450 isoforms to the metabolism of caffeine and to assess the usefulness of caffeine as a marker substance for estimating the activity of P450 in rat liver and its potential for

The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: An in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms

Kot, Marta,Daniel, Wladyslawa A.

, p. 543 - 551 (2008/12/20)

The aim of the present study was to estimate the relative contribution of cytochrome P450 isoforms (P450s), including P450s of the CYP2C subfamily, to the metabolism of caffeine in human liver. The experiments were carried out in vitro using cDNA-expresse

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 83-67-0